Wire Stories

CORRECTING and REPLACING IASO Receives NMPA Acceptance of its First Indication IND Application for CT120, a Fully Human CD19/CD22 Dual-Targeting CAR-T Therapy

PLEASANTON, Calif. & NANJING, China--(BUSINESS WIRE)--#Biopharmaceutical--First sentence of release should read: "...has been accepted by the China National Medical Products…

5 years ago

The program, now in its third year, focuses on how photonic devices are impacting quantum science, technology, and applications BELLINGHAM,…

5 years ago

Asia Pharmaceutical Directory 2021: Information on 10,000 Pharmaceutical and Biotechnology Companies – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asian Pharmaceutical Directory 2021" directory has been added to ResearchAndMarkets.com's offering. Keep up to date with the Asian…

5 years ago

AM Best Affirms Credit Ratings of Consumer Insurance Services Limited

SINGAPORE--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of B+ (Good) and the Long-Term Issuer Credit Rating of �bbb-�…

5 years ago

AM Best Affirms Credit Ratings of Consumer Insurance Services Limited

SINGAPORE--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of B+ (Good) and the Long-Term Issuer Credit Rating of �bbb-�…

5 years ago

Options Launch Market-Leading PTP Compliance Reporting Tool, Tempus

LONDON & NEW YORK & HONG KONG--(BUSINESS WIRE)--Options, the leading provider of managed trading infrastructure to the global Capital Markets,…

5 years ago

IASO Receives NMPA Acceptance of its First Indication IND Application for CT120, a Fully Human CD19/CD22 Dual-Targeting CAR-T Therapy

PLEASANTON, Calif. & NANJING, China--(BUSINESS WIRE)--#Biopharmaceutical--IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in the discovery and development of…

5 years ago

Guangzhou Bio-Gene Announces Oral Presentation at the 2021 ASCO Annual Meeting

GUANGZHOU, China--(BUSINESS WIRE)--Guangzhou Bio-Gene, a clinical-stage biopharmaceutical company developing a pipeline of innovative oncology therapies, today announced the company will…

5 years ago

Blaize Expands Asia-Pacific Distribution in Automotive, Retail, Metro and Industrial Markets via Partnership with Weikeng

Weikeng Group, a multi-billion operation with broad-based diversified customer base to distribute Blaize products in China, Taiwan, and Southeast Asia…

5 years ago

One Concern and SOMPO Expand Partnership to Develop Global Resilience Market With More Than $100 Million in Total Commitments by SOMPO

MENLO PARK, Calif.--(BUSINESS WIRE)--#AI--One Concern, Inc., today announced that SOMPO Holdings, Inc., has agreed to launch the next phase of…

5 years ago